The Craneware Group announces it supports and underwrites advocacy group 340B Matters

The Craneware Group (AIM: CRW.L), the healthcare market leader in automated value cycle solutions, today publicly announces it supports and underwrites the advocacy group 340B Matters.

In 2016, guided by a concern for the future of the 340B program, Sentry Data Systems, now The Craneware Group, launched 340B Matters. The core mission of the advocacy group is to protect the vital drug discount program from corporate entities aiming to severely restrict access to reduced-cost outpatient medications for nonprofit healthcare organizations. Known for candidly and without reservation tackling drug manufacturers that lobby for their own profits, 340B Matters also shines a light on pharma’s tendencies to AstroTurf struggling healthcare organizations, spreading false narratives and pitting safety-net providers against each other in a near-constant attempt to degrade the benefits of the 340B program. Under the slogan, we support patients over profits, the advocacy group lends a voice to all safety-net hospitals that provide accessible and affordable care to their most vulnerable populations.

“The Craneware Group, in stepping forward as the power behind 340BMatters, is demonstrating our continued and unwavering commitment to being more than just a revenue intelligence and 340B performance partner. We are committed to transforming the business of healthcare with our customers, closely engaging with them to achieve operational and financial goals that make healthcare more accessible and affordable for more people; including advocacy efforts to support safety-net providers and their mission to serve the unmet need in their communities.” – Keith Neilson, CEO

Read the full release from The Craneware Group here: https://www.thecranewaregroup.com/news-events/press-releases/2023/the-craneware-group-announces-it-supports-and-underwrites-advocacy-group-340b-matters/